Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)

被引：0
|
作者：
Jason T. Hurwitz
Shannon Vaffis
Amy J. Grizzle
Søren Nielsen
Andrew Dodson
Suzanne Parry
机构：
[1] University of Arizona,Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy
[2] Aalborg University Hospital,NordiQC, Institute of Pathology
[3] UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation,undefined
来源：
Oncology and Therapy | 2022年 / 10卷
关键词：
Advanced NSCLC; Cost-effectiveness; Diagnostic; Germany; PD-L1; Pembrolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：391 / 409
页数：18
相关论文
共 50 条
  • [31] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
    Gagne, Andreanne
    Wang, Emily
    Bastien, Nathalie
    Orain, Michele
    Desmeules, Patrice
    Page, Sylvain
    Trahan, Sylvain
    Couture, Christian
    Joubert, David
    Joubert, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
  • [32] PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays
    Munari, Enrico
    Zamboni, Giuseppe
    Lunardi, Gianluigi
    Marconi, Marcella
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Quatrini, Linda
    Vacca, Paola
    Moretta, Lorenzo
    Bogina, Giuseppe
    HUMAN PATHOLOGY, 2019, 90 : 54 - 59
  • [33] Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer
    Schatz, Stefanie
    Falk, Markus
    Jori, Balazs
    Ramdani, Hayat O.
    Schmidt, Stefanie
    Willing, Eva-Maria
    Menon, Roopika
    Groen, Harry J. M.
    Diehl, Linda
    Kroeger, Matthias
    Wesseler, Claas
    Griesinger, Frank
    Hoffknecht, Petra
    Tiemann, Markus
    Heukamp, Lukas C.
    CANCERS, 2020, 12 (06) : 1 - 14
  • [34] COST-EFFECTIVENESS OF THE SECOND LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Chang, C. W.
    Lang, H. C.
    VALUE IN HEALTH, 2019, 22 : S165 - S166
  • [35] COST-EFFECTIVENESS OF PRECISION DIAGNOSTIC TESTING AND PRECISION MEDICINE FOR NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW
    Henderson, R.
    Lawler, M.
    Keeling, P.
    French, D.
    Smart, D.
    Finucane, S.
    Sullivan, R.
    VALUE IN HEALTH, 2020, 23 : S33 - S33
  • [36] A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing
    Matter-Walstra, Klazien
    Schwenkglenks, Matthias
    Aebi, Stefan
    Dedes, Konstantin
    Diebold, Joachim
    Pietrini, Mario
    Klingbiel, Dirk
    von Moos, Roger
    Gautschi, Oliver
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1846 - 1855
  • [37] PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)
    Jiang, Liyan
    Su, Xinying
    Zhang, Tianwei
    Yin, Xiaolu
    Zhang, Meizhuo
    Fu, Haihua
    Han, Hulin
    Sun, Yun
    Dong, Lili
    Qian, Jialin
    Xu, Yanhua
    Fu, Xuan
    Gavine, Paul R.
    Zhou, Yanbin
    Tian, Kun
    Huang, Jiaqi
    Shen, Dong
    Jiang, Haiyi
    Yao, Yihong
    Han, Baohui
    Gu, Yi
    ONCOTARGET, 2017, 8 (16) : 26845 - 26857
  • [38] A Cost-Effectiveness Analysis of Actionable Genomic Alteration (AGA) Testing Strategies in Non-Small Cell Lung Cancer (NSCLC)
    Ang, Y.
    Ong, M. J. C.
    Wang, N.
    Rozali, E.
    Gibbs, M.
    Soo, R. A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S133 - S133
  • [39] Molecular diagnostic characteristics in non-small cell lung carcinomas ( NSCLC) and its relationship with the PD-L1 expression
    Sert, A.
    Sadioglu, A.
    Ekinci, O.
    Ogut, B.
    Inan, M. A.
    Akyurek, N.
    VIRCHOWS ARCHIV, 2024, 485 : S326 - S326
  • [40] Domain-specific PD-L1 protein measurement in non-small cell lung cancer (NSCLC)
    McLaughlin, Joseph Francis
    Schaiper, Kurt
    Carvajal-Hausdorf, Daniel E.
    Velcheti, Vamsidhar
    Haack, Herbert
    Silver, Matthew
    Goldberg, Sarah B.
    Herbst, Roy S.
    Rimm, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345